And from the ATHE 30/6/2020 annual report filing page 2
"...as we expand our research and development and pre-clinical activities and commence clinical trials of our product candidates that includes ATH434 for Parkinsonian diseases, prospectively PBT2 for alternative indications and the development of other compounds"
- Forums
- ASX - By Stock
- PBT2 further development!
And from the ATHE 30/6/2020 annual report filing page 2"...as we...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $200 | 66.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
53 | 75238609 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 4967441 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
53 | 75238609 | 0.002 |
23 | 117810099 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 4967441 | 3 |
0.004 | 132321201 | 25 |
0.005 | 22242406 | 25 |
0.006 | 23031950 | 19 |
0.007 | 47726651 | 22 |
Last trade - 10.00am 10/09/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |